英文綜説及び著書

43
Sawamura S, Shirakawa H, Nakagawa T, Mori Y & Kaneko S.
TRP channels in the brain: what are they there for? (Chapter 17)
In “Neurobiology of TRP channels” (ed. Rosenbaum T, CRC Press/Taylor and Francis Group, 2017)
42
Mori Y, Takahashi N, Kurokawa T & Kiyonaka S.
TRP channels in oxygen physiology: distinctive functional properties and roles of TRPA1 in O2 sensing.
Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 93, 464-482. (2017)
41
Ogawa N, Kurokawa T, Mori Y.
Sensing of redox status by TRP channels.
Cell Calcium. 60, 115-22 (2016)
40
Mori Y, Takahashi N, Ogawa N, Gudermann T.
Oxygen physiology: sensors and ion channels.
Pflugers Arch. 468, 1-2 (2016)
39
Mori Y, Takahashi N, Polat OK, Kurokawa T, Takeda N, Inoue M.
Redox-sensitive transient receptor potential channels in oxygen sensing and adaptation.
Pflugers Arch. 468, 85-97 (2016)
38
Kozai D, Sakaguchi R, Ohwada T & Mori Y.
Deciphering Subtype-Selective Modulations in TRPA1 Biosensor Channels.
Curr. Neuropharmacol. 13, 266-278 (2015)
37
Mori MX, Itsuki K, Hase H, Sawamura S, Kurokawa T, Mori Y & Inoue R.
Dynamics of receptor-operated Ca2+ currents through TRPC channels controlled via the PI(4,5)P2-PLC signaling pathway.
Front. Pharmacol. 6, 22 (2015)
36
Shimizu S, Yonezawa R, Hagiwara T, Yoshida T, Takahashi N, Hamano S, Negoro T, Toda T, Wakamori M, Mori Y, Ishii M.
Inhibitory effects of AG490 on H2O2-induced TRPM2-mediated Ca2+ entry
Eur J Pharmacol. 742C, 22-30 (2014)
35
Sakaguchi R, Kiyonaka S, Mori Y.
Fluorescent sensors reveal subcellular thermal changes.
Curr Opin Biotechnol. 31C, 57-64 (2014)
34
Kozai D, Ogawa N, Mori Y.
Redox regulation of transient receptor potential channels.
Antioxid Redox Signal. 21, 971-86 (2014)
33
Numata T, Ogawa N, Takahashi N, & Mori Y.
TRP channels as sensors of oxygen availability.
Pflugers Arch. 465, 1075-1085 (2013)
32
Takada Y, Numata T, & Mori Y.
Targeting TRPs in neurodegenerative disorders.
Curr. Top. Med. Chem. 13, 322-334 (2013)
31
Nakao A, Hirano M, Takada Y, Kiyonaka S, & Mori Y.
Molecular architecture of Ca2+ channel complexes organized by β subunits in presynaptic active zones.
In "Modulation of presynaptic calcium channels" springer (2013) (ISBN 978-94-007-6333-3)
30
Takahashi N, Kozai D, & Mori Y.
TRP channels: sensors and transducers of gasotransmitter signals.
Front. Physiol. 3, 324 (2012)
29
Takahashi N & Mori Y.
TRP channels as sensors and signal integrators of redox status changes.
Frontiers Pharmacol. 2, 58 (2011)
28
Mori Y, Kiyonaka S & Kanai Y.
Transportsomes and channelsomes: are they functional units for physiological responses? (A preface for the special issue “transportsomes and channelsomes” guest-edited by Mori Y as an associate editor)
Channels 5, 387-390 (2011)
27
Takahashi N, Kozai D, Kobayashi R, Ebert M & Mori Y.
Roles of TRPM2 in oxidative stress.
Cell Calcium 50, 279-290 (2011).
26
Mori Y, Kajimoto T, Nakao A, Takahashi N & Kiyonaka S.
Receptor signaling integration by TRP channelsomes.
In “Advances in Experimental Medicine and Biology: Transient Receptor Potential Channels” (ed Islam S, Springer, 2011) 704, 373-89.
25
Numata T, Kiyonaka S, Kato K, Takahashi N & Mori Y.
Activation of TRP channels in mammalian systems.
In “Handbook of Experimental Pharmacology: TRP channels in health and disease” (ed Zhu MX, CRC press, 2011) 43-90.
24
Koike C, Numata T, Ueda H, Mori Y & Furukawa T.
TRPM1: a vertebrate TRP channel responsible for retinal ON bipolar function.
Cell Calcium 45, 95-101 (2010).
23
Yamamoto S, Takahashi N & Mori Y.
Chemical Physiology of Oxidative Stress-Activated TRPM2 and TRPC5 Channel.
Prog. Biophys. Mol. Biol. 103, 18-27 (2010).
22
Yamamoto S, Wajima T, Hara Y, Nishida M & Mori Y.
Transient Receptor Potential Channels in Alzheimer's Disease.
Biochim. Biophys. Acta. - Molecular Basis of Disease 1772, 958-967 (2007).
21
Numaga T, Wakamori M & Mori Y.
TRPC7.
In “Handbook of Experimental Pharmacology: TRP channels in health and disease” 179, 143-51 (2007).
20
Nishida M, Hara Y, Yoshida T, Inoue R & Mori Y.
TRP channels: molecular diversity and physiological function.
Microcirculation 13, 535-550 (2006).
19
Sugimoto K, Sakaguchi R, Mori Y & Morii T.
Recent advances in biosensing second messengers.
Recent Res. Devel. Chem. 2, 73-89 (2004).
18
Mori Y, Itsukaichi Y, Nishida M & Oka H.
Ca2+ channel mutations and associated diseases.
In “Ca channel pharmacology book” 303-330 (ed. McDonough S, Kluwer Academic/ Plenum Publishers, 2004).
17
Inoue R, Hanano T, Shi J, Mori Y & Ito Y.
TRP proteins as a novel non-voltage Ca2+ entry channel involved in diverse pathophysiological function.
J. Pharmacol. Sci. 91, 271-276 (2003).
16
Inoue R & Mori Y.
New target molecules in the drug control of blood pressure and circulation.
Current Drug Targets- Cardiovascular & Hematological Disorders 3, 59-72 (2003).
15
Inoue R & Mori Y.
Molecular candidates for capacitative and non-capacitative Ca2+ entry in smooth muscle.
In “Role of the Sarcoplasmic Reticulum in Smooth Muscle.” Novartis Foundation Symposium Volume 246 (ed. Eisner D, Wiley and Sons Ltd., Chichester, UK) 246, 81-90; discussion 221-7 (2002).
14
Mori Y, Nishida M, Ino M, Yoshinaga T, Niidome T & Sawada K.
Mice lacking the α1B subunit (CaV 2.2) reveals a predominant role of N-type Ca2+ channels in the sympathetic regulation of circulatory system.
Trends Cardiovasc. Med. 12, 270-274 (2002).
13
Montell C, Birnbaumer L, Flokerzi V, Bindels RJ, Bruford EA, Caterina MJ, Clapham DE, Harteneck C, Heller S, Julius D, Mori Y, Penner R, Prawitte D, Scharenberg AM, Schultz G, Shimizu N & Zhu MX.
A unified nomenclature for the superfamily of TRP cation channels.
Mol. Cell 9, 229-231 (2002).
12
Mori Y, Inoue R, Ishii M, Hara Y & Imoto K.
Dissecting receptor-mediated Ca2+ influx pathways: TRP channels and their native counterparts.
Jpn. J. Pharmacol. 87, 245-252 (2001).
11
Mori Y.
Receptor-activated Ca2+ influx: TRP proteins and capacitative Ca2+ entry.
In “Control and diseases of sodium dependent transport and ion channels” 163-176 (ed Suketa Y, Carafoli E, Lazdunski M, Mikoshiba K, Okada Y & Wright EM, Elsevier, 2000).
10
Ertel E, Campbell KP, Harpold MM, Hofmann F, Mori Y, Perez-Reyes E, Schwartz A, Snutch T, Tanabe T, Birnbaumer L, Tsien RW & Catterall WA.
Nomenclature of voltage-gated calcium channels.
Neuron 25, 533-535 (2000).
9
Uneyama E, Takahara A, Wakamori M, Mori Y & Yoshimoto R.
Pharmacology of N-type Ca2+ channels distributed in cardiovascular system.
Int. J. Mol. Med. 3, 455-466 (1999).
8
Kobayashi T & Mori Y.
Ca2+ channel antagonists and neuroprotection from cerebral ischemia.
Eur. J. Parmacol. 363, 1-15 (1998).
7
Mikala G, Varadi G, Kobayashi T, Koch S, Wakamori M & Schwartz A Mori Y.
Molecular pharmacology of voltage-dependent calcium channels.
Jpn. J. Pharmacol. 72, 83-109 (1996).
6
Varadi G, Mori Y, Mikala G & Schwartz A.
Molecular determinants of calcium channel action and drug sites.
Trends Prarmacol. 16, 43-49 (1995).
5
Heinemann SH, Schlief T, Mori Y & Imoto K.
Molecular pore structure of voltage-activated sodium and calcium channels.
Brazilian J. Medic. Biol. Res. 27, 2781-2802 (1994).
4
Birnbaumer L, Campbell KP, Catterall WA, Harpold MM, Hofmann F, Horne WA, Mori Y, Schwartz A, Snutch TP, Tanabe T & Tsien R.
The naming of voltage-gated calcium channels.
Neuron 13, 505-506 (1994).
3
Mori Y.
Molecular biology of voltage-dependent calcium channels.
In “Handbook of Membrane Channels: Molecular and Cellular Physiology” 163-176 (ed Peracchia C, Academic Press,1994).
2
Niidome T & Mori Y.
Primary structure and tissue distribution of a novel calcium channel from rabbit brain.
Ann. NY Acad. Sci. 707, 368-324 (1993).
1
Mori Y, Niidome T, Fujita Y, Mynlieff M, Dirksen RT, Beam KG, Iwabe N, Miyata T, Furuichi T, Furutama D & Mikoshiba K.
Molecular diversity of voltage-dependent calcium channels.
Ann. NY Acad. Sci. 707, 87-108 (1993).